1. CBX8 Exhibits Oncogenic Activity via AKT/β-Catenin Activation in Hepatocellular Carcinoma
   Chris Zhiyi Zhang et al, 2018, Cancer Research CrossRef
2. microRNAs: Key players in virus‐associated hepatocellular carcinoma
   Javid Sadri Nahand et al, 2019, Journal of Cellular Physiology CrossRef
3. HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma
   Fabrizio Bronte et al, 2016, Critical Reviews in Oncology/Hematology CrossRef
4. miR-101 Inhibiting Cell Proliferation, Migration and Invasion in Hepatocellular Carcinoma through Downregulating Girdin
   Ke Cao et al, 2016, Molecules and Cells CrossRef
5. Single Nucleotide Polymorphisms ofCBX4andCBX7Decrease the Risk of Hepatocellular Carcinoma
   Chao Tan et al, 2019, BioMed Research International CrossRef
6. Therapeutic Potential of Targeting the SUMO Pathway in Cancer
   Antti Kukkula et al, 2021, Cancers CrossRef
7. MicroRNA dysregulation interplay with childhood abdominal tumors
   Karina Bezerra Salomão et al, 2019, Cancer and Metastasis Reviews CrossRef
8. Downregulation of microRNA-195 promotes angiogenesis induced by cerebral infarction via targeting VEGFA
   Wen-Jing Zhao et al, 2017, Molecular Medicine Reports CrossRef
9. MicroRNA-195 inhibits the proliferation and invasion of pancreatic cancer cells by targeting the fatty acid synthase/Wnt signaling pathway
   Zhichao Xu et al, 2017, Tumor Biology CrossRef
10. The SUMO E3 ligase CBX4 is identified as a poor prognostic marker of gastric cancer through multipronged OMIC analyses
    Yi Pan et al, 2021, Genes & Diseases CrossRef
11. MicroRNA-195 inhibits cell proliferation, migration and invasion in laryngeal squamous cell carcinoma by targeting ROCK1
    Yang Liu et al, 2017, Molecular Medicine Reports CrossRef
12. miRNA arm switching identifies novel tumour biomarkers
    Liang Chen et al, 2018, eBioMedicine CrossRef
13. Epigenetic Regulations in the Pathogenesis of HCC and the Clinical Application
    Williams Puszyk et al, 2018, Precision Molecular Pathology of Liver Cancer CrossRef
14. Dysregulated miRNA in progression of hepatocellular carcinoma: A systematic review
    Yoshiaki Mizuguchi et al, 2016, Hepatology Research CrossRef
15. CBX4 Expression and AFB1-Related Liver Cancer Prognosis
    Qun-Ying Su et al, 2018, Cancer Prognosis CrossRef
16. EGR1 interacts with DNMT3L to inhibit the transcription of miR‐195 and plays an anti‐apoptotic role in the development of gastric cancer
    Yang Yang et al, 2019, Journal of Cellular and Molecular Medicine CrossRef
17. Identification of miR-195-3p as an oncogene in RCC
    Lu Jin et al, 2017, Molecular Medicine Reports CrossRef
18. Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway
    Regina Cheuk-Lam Lo et al, 2018, Cell Death & Differentiation CrossRef
19. MicroRNA‑205 is downregulated in hepatocellular carcinoma and inhibits cell growth and metastasis via directly targeting vascular endothelial growth factor A
    Xuya Zhao et al, 2018, Oncology Letters CrossRef
20. Transcriptional expressions of Chromobox 1/2/3/6/8 as independent indicators for survivals in hepatocellular carcinoma patients
    Gang Ning et al, 2018, Aging CrossRef
21. Potential microRNA-related targets in clearance pathways of amyloid-β: novel therapeutic approach for the treatment of Alzheimer’s disease
    Soheil Madadi et al, 2019, Cell & Bioscience CrossRef
22. Functional Network Analysis Reveals the Relevance of SKIIP in the Regulation of Alternative Splicing by p38 SAPK
    Caterina Carbonell et al, 2019, Cell Reports CrossRef
23. Long Noncoding RNA MIR100HG Knockdown Attenuates Hepatocellular Carcinoma Progression by Regulating MicroRNA-146b-5p/Chromobox 6
    Fushun Li et al, 2021, Gastroenterology Research and Practice CrossRef